Treatments for Upper tract urothelial carcinoma

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.

Report missing data

FDA-approved treatments (3)

OPDIVO
NIVOLUMAB
E.R. Squibb & Sons, L.L.C.
Jelmyto
mitomycin
UroGen Pharma, Ltd.
Approved Apr 2020
Renacidin Irrigation
Citric acid, glucono-delta-lactone and magnesium carbonate
United-Guardian, Inc.
Approved Oct 1990

Patient support programs (2)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

Renacidin Irrigation

United-Guardian, Inc.

Unverified — confirm before calling

copay card

copay assistancePatient Assistance

Accepting applications

Jelmyto

UroGen Pharma, Ltd.

Jelmyto — Contact UroGen Pharma, Ltd.

Unverified — confirm before calling

Patient Assistance

Manufacturer Program

Accepting applications

More about Upper tract urothelial carcinoma

Disease overview →
Specialists →
Clinical trials →